The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responses.
J Clin Invest. 2022 Jan 4;132(1):e147334. doi: 10.1172/JCI147334.
J Clin Invest. 2022.
PMID: 34981775
Free PMC article.